Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Intelligence Squared Debates: Legalize Psychedelics

April 22nd 4:30PM - 6:00PM (EST)

Psychedelics, in medical terms, is an inexact category of drugs that affect perceptions and cognition. Their proponents say 1960s-era associations have undermined exciting research in the field of neuroscience.

Psychedelics should be made much more widely available, they contend, to treat a range of mental and emotional issues, as well as to ascertain a more profound sense of ourselves. People should also be empowered to make their own decisions in its use.

Not so fast, say opponents. These are powerful substances. And society does not know enough about the broader consequences of greatly increasing access. Cautionary tales should be heeded. Either way, like cannabis, the movement for wider use is growing.

So... here’s our debate: Should society legalize psychedelics?

Presenters

Presenter
FOR THE MOTION
Rick Doblin
Founder & Executive Director, Multidisciplinary Association for Psychedelic Studies
View Biography
Presenter
FOR THE MOTION
Beatriz Labate
Anthropologist & Drug Policy Expert
View Biography
Presenter
AGAINST THE MOTION
Jeffrey Lieberman
Professor & Chair, Department of Psychiatry, Columbia University
View Biography
Presenter
AGAINST THE MOTION
Kevin Sabet
President & CEO, Smart Approaches to Marijuana
View Biography
Presenter
John Donvan
Host & Moderator
Intelligence Squared U.S
View Biography